(COSM) Cosmos Health - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2214132068
COSM: Vitamins, Minerals, Dietary, Medicines, Medical Devices, Baby Products
Cosmos Health Inc. (NASDAQ:COSM) is a U.S.-based company specializing in the manufacturing, development, and distribution of branded nutraceutical and healthcare products. Established in 2009 and headquartered in Chicago, Illinois, the company operates primarily in Greece, the United Kingdom, Croatia, Bulgaria, the Cayman Islands, and Cyprus. Its product portfolio includes prescription and over-the-counter (OTC) medications, vitamins, minerals, dietary supplements, medical devices, baby products, and other health-related items. These products are marketed under the Sky Premium Life and Mediterranation brand names, targeting wholesale distributors, healthcare providers, clinics, government agencies, and independent pharmacies. The companys distribution network relies on independent wholesale distributors to reach its customer base.
From a technical perspective, COSM has shown a declining trend over the past 200 days, with its SMA 20 and SMA 50 below the SMA 200. The stock is currently trading at $0.51, below its short-term and medium-term moving averages. The ATR of 0.08 indicates low volatility, suggesting a stable but bearish trajectory in the near term. The average 20-day volume of 304,217 shares reflects moderate trading activity.
Fundamentally, the company has a market capitalization of $13.72 million, with a price-to-book (P/B) ratio of 0.37, indicating undervaluation relative to its book value. The forward P/E of 56.18 suggests high expectations for future earnings, though the current P/E is negative due to operating losses. The price-to-sales (P/S) ratio of 0.24 points to undervaluation relative to revenue. However, the return on equity (RoE) of -58.30% highlights significant profitability challenges.
Additional Sources for COSM Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
COSM Stock Overview
Market Cap in USD | 12m |
Sector | Healthcare |
Industry | Medical Distribution |
GiC Sub-Industry | Health Care Distributors |
IPO / Inception | 2012-10-11 |
COSM Stock Ratings
Growth 5y | -80.3% |
Fundamental | -47.1% |
Dividend | 0.0% |
Rel. Strength Industry | -31.8 |
Analysts | 4/5 |
Fair Price Momentum | 0.22 USD |
Fair Price DCF | - |
COSM Dividends
No Dividends PaidCOSM Growth Ratios
Growth Correlation 3m | -58.7% |
Growth Correlation 12m | -10.3% |
Growth Correlation 5y | -91% |
CAGR 5y | -62.78% |
CAGR/Max DD 5y | -0.63 |
Sharpe Ratio 12m | -0.91 |
Alpha | -54.18 |
Beta | 2.63 |
Volatility | 113.52% |
Current Volume | 63.2k |
Average Volume 20d | 214.8k |
As of March 17, 2025, the stock is trading at USD 0.48 with a total of 63,233 shares traded.
Over the past week, the price has changed by +2.71%, over one month by -21.62%, over three months by -30.83% and over the past year by -30.87%.
Probably not. Based on ValueRay Fundamental Analyses, Cosmos Health (NASDAQ:COSM) is currently (March 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -47.10 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of COSM as of March 2025 is 0.22. This means that COSM is currently overvalued and has a potential downside of -54.17%.
Cosmos Health has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy COSM.
- Strong Buy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, COSM Cosmos Health will be worth about 0.3 in March 2026. The stock is currently trading at 0.48. This means that the stock has a potential downside of -43.75%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 3 | 525% |
Analysts Target Price | 3 | 525% |
ValueRay Target Price | 0.3 | -43.8% |